About us
Our Mission
Since our establishment in 2010, we empower individuals with advanced, home-use photobiomodulation technology and foster scientific breakthroughs.
As the original inventors of home-use brain photobiomodulation technology, we lead with the most industry patents, ranging from AI to neuromodulation.
Our patented brain-systemic photobiomodulation technology has demonstrated efficacy in independent pilot and clinical trials for severe conditions, with over 500 clinical trial participants.
Through our steadfast dedication to collaborative research with the brightest minds, our technology participates in the most published studies and ongoing clinical trials on a global scale.
We are certified as a medical device manufacturer under MDSAP and ISO 13485.
Who we are
The technology of Vielight dates back to 1995 in the Silicon Valley, California – when the founders, Dr. Lew Lim and a group of engineers explored the potential of intranasal photobiomodulation. Intranasal photobiomodulation devices were commercially developed in 2003, which were later trademarked as “Vielight” when the company was incorporated in 2011.
Over the years, our focus shifted towards the development of unique photobiomodulation devices which enhance cognition and performance, among other things.
Today, our team has since evolved into a formidable team of engineers, scientists and business professionals dedicated to bringing the technology to as many people as possible.
Our dedication to research
Attaining our goal of helping people through photobiomodulation would not be possible without the right people. That is why Vielight have gathered many bright minds from a diverse range of scientific backgrounds to continuously improve the efficacy of brain and systemic photobiomodulation technology.
